Wyva
Senior Member (Voting Rights)
195th General Assembly of the Hungarian Academy of Sciences -
The long COVID syndrome: Lingering illness after the pandemic
Date: 5th May, it can be followed online.
Programme:
My comment: some of you may remember that they organized a long covid symposium a few months ago. It was mostly about the organic problems after covid (and you can see this one is also about all the different post-covid sequelae). Only one person, Professor Janszky, a neurologist talked about the ME/CFS-like long covid and he also talked about ME/CFS itself. That was pretty much a disaster: instead of sharing knowledge about the disease we had to listen to how awful the patients are with their war on poor scientists, they even threatened them etc and that NICE, Cochrane are all under the patient activists' influence. And it is because of all these problems, this war that long covid is not called ME/CFS, to prevent the same thing happening with these patients. I complained to the Academy in a letter afterwards but they pretty much dismissed it by talking about totally different things, not the issues I raised. This time, professor Janszky will talk about the neurological problems of LC again, so can't wait.
I can see a few speakers from the US but I'm not familiar with their names.
The two women talking about therapies are from the field of pharmacology.
The long COVID syndrome: Lingering illness after the pandemic
Date: 5th May, it can be followed online.
Programme:
Chairs: Veronika Müller, Sándor Szabó
10.00–10.05 Opening remarks - Veronika Ádám, Section President of Section of Medical Sciences of HAS (Hungary)
10.05–10.25 What is really ‘Long COVID’? - Veronika Müller (Hungary); Sándor Szabó (USA)
10.25–10.45 Lessons from the COVID-19 mRNA vaccine development - Katalin Karikó (Germany–USA)
10.45–11.05 COVID-19 is, in the end, an endothelial disease - Peter Libby (USA)
11.05–11.25 The main cardiovascular manifestations of Long COVID - Béla Merkely (Hungary)
11.25–11.45 Fatigue, dyspnea & pulmonary signs in Long COVID - Veronika Müller (Hungary)
11.45–12.05 The neurologic manifestations of Long COVID - József Janszky, Tamás Dóczi (Hungary)
12.05–13.00 Lunch break
13.00–13.20 Nutritional deficiencies that may predispose to Long COVID - John Schloss (USA)
13.20–13.40 The post-COVID stress syndrome & other neuroendocrine changes in Long COVID - Sándor Szabó (USA)
13.40–14.00 Specific coronavirus associated disease in children: MISC - Attila Szabó (Hungary)
14.00–14.20 The current therapeutic options for Long COVID - Klára Gyires, Szilvia Sebők (Hungary)
14.20–14.40 Break / Szünet
14.40–15.00 The socioeconomic impact of COVID-19 - Zoltán Ács (UK–USA)
15.00–15.40 The prevalence & incidence of Long COVID in Ukraine, Greece, Germany & Hungary - The 4 senior investigators in our grants from these countries
15.40–16.00 Round table discussion
16.00–16.20 Q & A
My comment: some of you may remember that they organized a long covid symposium a few months ago. It was mostly about the organic problems after covid (and you can see this one is also about all the different post-covid sequelae). Only one person, Professor Janszky, a neurologist talked about the ME/CFS-like long covid and he also talked about ME/CFS itself. That was pretty much a disaster: instead of sharing knowledge about the disease we had to listen to how awful the patients are with their war on poor scientists, they even threatened them etc and that NICE, Cochrane are all under the patient activists' influence. And it is because of all these problems, this war that long covid is not called ME/CFS, to prevent the same thing happening with these patients. I complained to the Academy in a letter afterwards but they pretty much dismissed it by talking about totally different things, not the issues I raised. This time, professor Janszky will talk about the neurological problems of LC again, so can't wait.
I can see a few speakers from the US but I'm not familiar with their names.
The two women talking about therapies are from the field of pharmacology.